Supernus Pharmaceuticals (SUPN) EPS (Basic) Growth (3y) (2014 - 2026)
Supernus Pharmaceuticals (SUPN) EPS (Basic) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | -304.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -304.62% |
| Dec 31, 2025 | -29.13% |
| Sep 30, 2025 | -198.27% |
| Jun 30, 2025 | 39.73% |
| Mar 31, 2025 | -34.64% |
| Dec 31, 2024 | 82.20% |
| Sep 30, 2024 | 19.91% |
| Jun 30, 2024 | -6.83% |
| Mar 31, 2024 | -71.05% |
| Dec 31, 2023 | -66.72% |
| Sep 30, 2023 | -33.61% |
| Mar 31, 2023 | -8.71% |
| Dec 31, 2022 | -9.06% |
| Sep 30, 2022 | -61.05% |
| Jun 30, 2022 | -38.23% |
| Mar 31, 2022 | 11.09% |
| Dec 31, 2021 | -54.80% |
| Sep 30, 2021 | -8.91% |
| Jun 30, 2021 | -8.90% |
| Mar 31, 2021 | -40.52% |